Skip to main content
ImmuneCited

Curcumin Рисунки

12 иллюстрации из рецензируемых исследований

Все Pelargonium sidoides Glutathione N-Acetylcysteine Astragalus Conjugated Linoleic Acid Curcumin Arginine Astaxanthin Cordyceps Omega-3 Fatty Acids (EPA/DHA) Zinc Quercetin Elderberry Resveratrol Vitamin D Andrographis Iron
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Figure 1
Figure 1

Curcumin mitigates polycystic ovary syndrome in mice by suppressing TLR4/MyD88/NF-κB signaling pathway …

Figure 2
Figure 2

Curcumin mitigates polycystic ovary syndrome in mice by suppressing TLR4/MyD88/NF-κB signaling pathway …

Figure 3
Figure 3

Curcumin mitigates polycystic ovary syndrome in mice by suppressing TLR4/MyD88/NF-κB signaling pathway …

Figure 4
Figure 4

Curcumin mitigates polycystic ovary syndrome in mice by suppressing TLR4/MyD88/NF-κB signaling pathway …

Figure 5
Figure 5

Curcumin mitigates polycystic ovary syndrome in mice by suppressing TLR4/MyD88/NF-κB signaling pathway …

Figure 6
Figure 6

Curcumin mitigates polycystic ovary syndrome in mice by suppressing TLR4/MyD88/NF-κB signaling pathway …

Figure 1. Role of lysosomal dysfunction in the progression of cardiovascular disease (CVD). Lysosomal dysfunction, characterized by lysosomal membrane permeabilization and lipid accumulation, leads to the release of cathepsins and reactive oxygen species
Figure 1

Figure 1. Role of lysosomal dysfunction in the progression of cardiovascular disease (CVD). Lysosomal dysfunction, characterized by lysosomal membrane permeabilization and lipid accumulation, leads to the release of cathepsins and …

Lysosomal Stress in Cardiovascular Diseases: Therapeutic Potential of Cardiovascular Drugs and Future …

Figure 2. Therapeutic strategies targeting lysosomal dysfunction in cardiovascular diseases. This schematic illustrates lysosomal dysfunction as a central contributor to CVDs and highlights emerging therapeutic strategies targeting these pathways. Lysosom
Figure 2

Figure 2. Therapeutic strategies targeting lysosomal dysfunction in cardiovascular diseases. This schematic illustrates lysosomal dysfunction as a central contributor to CVDs and highlights emerging therapeutic strategies targeting these pathways. Lysosomal …

Lysosomal Stress in Cardiovascular Diseases: Therapeutic Potential of Cardiovascular Drugs and Future …

Figure 3
Figure 3

Lysosomal Stress in Cardiovascular Diseases: Therapeutic Potential of Cardiovascular Drugs and Future …

Figure 4
Figure 4

Lysosomal Stress in Cardiovascular Diseases: Therapeutic Potential of Cardiovascular Drugs and Future …

Figure 2. The role of osteopontin in regulating cell survival and cell death pathways. OPN: osteopontin; PI3K/Akt: phosphatidylinositol 3-kinase/protein kinase B; MAPK: mitogen-activated protein kinase; ERK: extracellular signal-regulated kinase; JNK: c-J
Figure 67

Figure 2. The role of osteopontin in regulating cell survival and cell death pathways. OPN: osteopontin; PI3K/Akt: phosphatidylinositol 3-kinase/protein kinase B; MAPK: mitogen-activated protein kinase; ERK: extracellular signal-regulated kinase; JNK: …

Osteopontin in Chronic Inflammatory Diseases: Mechanisms, Biomarker Potential, and Therapeutic Strategies.

Figure 147
Figure 147

Osteopontin in Chronic Inflammatory Diseases: Mechanisms, Biomarker Potential, and Therapeutic Strategies.